Yeh, Li Ren .

HRN: 22-25-44  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2022
CEFUROXIME 1.5GM (VIAL)
11/26/2022
12/02/2022
IVT
300mg
Q8
ATP, URTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  URTIEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: